Cecilia Carnrot

Structures of thymidine kinase 1 of human and mycoplasmic origin

M. Welin, U. Kosinska, Nils-Egil Mikkelsen et al. · Proceedings of the National Academy of Sciences · 2004 · 149 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Molecular characterization of thymidine kinase from <i>Ureaplasma urealyticum</i>: nucleoside analogues as potent inhibitors of <i>mycoplasma</i> growth

Cecilia Carnrot, Rahma Wehelie, Staffan Eriksson et al. · Molecular Microbiology · 2003 · 47 citations

Life Sciences, Biochemistry, Molecular Biology +13

Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial

Sarah E. Silk, Wilmina F. Kalinga, Jo Salkeld et al. · The Lancet Infectious Diseases · 2024 · 45 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Structure of the substrate complex of thymidine kinase from <i>Ureaplasma urealyticum </i>and investigations of possible drug targets for the enzyme

U. Kosinska, Cecilia Carnrot, Staffan Eriksson et al. · FEBS Journal · 2005 · 36 citations · Full text

Life Sciences, Cell Biology, Drug Discovery +7

Marginal zone B cells are naturally reactive to collagen type II and are involved in the initiation of the immune response in collagen-induced arthritis

Cecilia Carnrot, Kajsa E. Prokopec, Kristina Råsbo et al. · Cellular and Molecular Immunology · 2011 · 35 citations · Full text

Life Sciences, Immunology, Pathology +16